Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
Bupropion Nitroso Impurity 2
| CAT No | SRC-N0142627 |
| CAS No | NA |
| Mol.F. | C14H19ClN2O3 |
| Mol.Wt. | 298.8g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bupropion 3,4-Dichloro Impurity
| CAT No | SRC-N0142628 |
| CAS No | NA |
| Mol.F. | C13H16Cl2N2O2 |
| Mol.Wt. | 303.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bupropion USP Related Compound A
| CAT No | SRC-N0142629 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O2 |
| Mol.Wt. | 268.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bupropion USP Related Compound B
| CAT No | SRC-N0142630 |
| CAS No | NA |
| Mol.F. | C13H17BrN2O2 |
| Mol.Wt. | 313.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
(3S,5S,6S)-Bupropion Nitroso Impurity
| CAT No | SRC-N0142631 |
| CAS No | NA |
| Mol.F. | C12H13ClN2O4S |
| Mol.Wt. | 316.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bupropion 2'-Chloro Analog
| CAT No | SRC-N0142632 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O2 |
| Mol.Wt. | 268.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bupropion 3,5-Dichloro Impurity
| CAT No | SRC-N0142633 |
| CAS No | NA |
| Mol.F. | C13H16Cl2N2O2 |
| Mol.Wt. | 303.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bupropion Hydroxy Cyclic Impurity
| CAT No | SRC-N0142634 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O3 |
| Mol.Wt. | 284.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone EP Impurity E
| CAT No | SRC-N0142635 |
| CAS No | NA |
| Mol.F. | C21H32N6O4 |
| Mol.Wt. | 432.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone EP Impurity F
| CAT No | SRC-N0142636 |
| CAS No | NA |
| Mol.F. | C33H50N10O4 |
| Mol.Wt. | 650.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone EP Impurity J
| CAT No | SRC-N0142637 |
| CAS No | NA |
| Mol.F. | C34H51N7O6 |
| Mol.Wt. | 653.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone EP Impurity K
| CAT No | SRC-N0142638 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone Impurity 3
| CAT No | SRC-N0142639 |
| CAS No | NA |
| Mol.F. | C11H10N4O3 |
| Mol.Wt. | 246.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone Impurity 5
| CAT No | SRC-N0142640 |
| CAS No | NA |
| Mol.F. | C25H40N6O4 |
| Mol.Wt. | 488.63 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Buspirone Impurity 6
| CAT No | SRC-N0142641 |
| CAS No | NA |
| Mol.F. | C23H36N6O4 |
| Mol.Wt. | 460.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-N-DiNitroso Bendamustine Impurity 2
| CAT No | SRC-N01426412 |
| CAS No | NA |
| Mol.F. | C13H14ClN5O4 |
| Mol.Wt. | 339.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |